DAYVIGO
Identification of Dayvigo
| No description |
Google image searchProduct monograph
Active ingredient
lemborexant, 5 MG
DIN: 02507366
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: EISAI LIMITED
Date: 06-NOV-2020
ATC:
- N05 — PSYCHOLEPTICS (ATC, ATC/DDD, )
- N05C — HYPNOTICS AND SEDATIVES (ATC, ATC/DDD)
- N05CJ — Orexin receptor antagonists (ATC, ATC/DDD)
- N05CJ02 — LEMBOREXANT (ATC/DDD)
